Predictor Keberhasilan Pengobatan Tuberkulosis Tahun 2018 di Indonesia

Authors

  • riezky febiola
  • Mondastri Korib Sudaryo
  • Sri Ulfa Alriani

DOI:

https://doi.org/10.35473/proheallth.v2i2.561

Keywords:

Success, TB

Abstract

Tuberculosis is still a major cause of health problems and death due to infectious agents. The success rate of TB treatment varies globally where Asia is 81.6% the second highest after Oceania 83.9%. The prevalence of tuberculosis with bacteriological confirmation in Indonesia is 759 per 100,000 population. This study aims to determine the relationship between the independent variabel with the success of TB treatment in Indonesia in 2018. Methods This study was conducted using a retrospective cohort study design. The study population was all TB Drug Sensitive patients who started treatment in 2018 and were recorded on SITT. Data analysis was performed using Chi Square. 392,706 TB patients were included in the analysis of 476,744 patients. With treatment results 45.2% recovered, 43.35% complete treatment, 3% died, 0.8% failed, 5.6% dropped out of treatment, 2.1% people moved. Age> 45 years RR 1,028 (95% CI; 1,009-1,049), female gender 1,022 (95% CI; 1,004-1,041), HIV negative 1,229 (95% CI; 1,169-1,292), patients with new treatment status RR 1,072 (95% CI; 1.033-1.112) and did not have a DM RR comorbid 1.027 (95% CI; 1.003-1.051) were predictors of the success of TB treatment. The results of this study indicate that patients who do not have HIV or DM co-morbidities are more likely to succeed in TB treatment.

References

WHO | Global tuberculosis report 2018. 2018.

Kementerian Kesehatan RI. Info Data dan Informasi Tuberkulosis Tahun 2018. 2018;1–6.

Kemenkes. Permenkes Nomor 67 Tahun 2016 tentang Penanggulangan Tuberkulosis. 2016;

Dirjen P2P. Evaluasi Program Tuberkulosis 2018 Upaya Menuju Eliminasi. 2018;

Raviglione M, Sulis G. Tuberculosis 2015: Burden, challenges and strategy for control and elimination. Infect Dis Rep. 2016;8(2):33–7.

Dye C. Global epidemiology of tuberculosis. Lancet. 2006;367(9514):938–40.

Torres NMC, Rodríguez JJQ, Andrade PSP, Arriaga MB, Netto EM. Factors predictive of the success of tuberculosis treatment: A systematic review with meta-analysis. PLoS One. 2019;14(12):1–24.

Tesfahuneygn G, Medhin G, Legesse M. Adherence to Anti ‑ tuberculosis treatment and treatment outcomes among tuberculosis patients in Alamata District , northeast Ethiopia. BMC Res Notes. 2015;1–11.

Tola A, Minshore KM, Ayele Y, Mekuria AN. Tuberculosis Treatment Outcomes and Associated Factors among TB Patients Attending Public Hospitals in Harar Town, Eastern Ethiopia: A Five-Year Retrospective Study. Tuberc Res Treat. 2019;2019:1–11.

Vasankari T, Holmström P, Ollgren J, Liippo K, Kokki M, Ruutu P. Risk factors for poor tuberculosis treatment outcome in Finland : a cohort study. 2007;9:1–9.

Berhe G, Enquselassie F, Aseffa A. Treatment outcome of smear-positive pulmonary tuberculosis patients in Tigray Region , Northern Ethiopia. 2012;

Ahmad T, Haroon, Khan4 M, Khan5 MM, Ejeta6 E, Karami7 M, et al. Treatment Outcome of Tuberculosis Patients Under Directly Observed Treatment Short Course and its Determinants in Shangla, Khyber‑Pakhtunkhwa, Pakistan: A Retrospective Study. Int J Mycobacteriology. 2017;6(3):239–45.

Worku S, Derbie A, Mekonnen D, Biadglegne F. Treatment outcomes of tuberculosis patients under directly observed treatment short-course at Debre Tabor General Hospital, northwest Ethiopia: Nine-years retrospective study. Infect Dis Poverty. 2018;7(1):1–7.

Dooley KE, Tang T, Golub JE, Dorman SE, Cronin W. Impact of Diabetes Mellitus on Treatment Outcomes of Patients with Active Tuberculosis. 2009;80(4):634–9.

Lönnroth K, Roglic G, Harries AD. Improving tuberculosis prevention and care through addressing the global diabetes epidemic: From evidence to policy and practice. Lancet Diabetes Endocrinol. 2014;2(9):730–9.

Melese A, Zeleke B. Factors associated with poor treatment outcome of tuberculosis in Debre Tabor, northwest Ethiopia. BMC Res Notes [Internet]. 2018;11(1):1–6. Available from: https://doi.org/10.1186/s13104-018-3129-8

Published

2020-08-04

Issue

Vol. 2 No. 2 (2020): Pro Health Jurnal Ilmiah Kesehatan, July 2020

Section

Articles

License

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

  1. The submission file is in OpenOffice, Microsoft Word, RTF, or WordPerfect document file format.
  2. Below the abstract, about three to five keywords should appear together with the main body of the article with the font size 11.
  3. Institutional affiliations, and the email address of the corresponding author should appear only on a detachable cover sheet.
  4. If submitting to a peer-reviewed section of the journal, the instructions in Ensuring a Blind Review have been followed.
  5. Citation is done using bracket (last name and year of publication). When the sources are cited verbatim, page number is included (p. 78 or pp. 78-89).